Literature DB >> 10379048

Cytokine/chemokine cascades in immunity to tuberculosis.

I M Orme1, A M Cooper.   

Abstract

The relationship between acquired specific resistance and delayed-type hypersensitivity (DTH) in immunity to tuberculosis has long been a topic of debate. Here, Ian Orme and Andrea Cooper propose that the events are separate mechanisms; protection is cytokine driven and initially controls the infection, whereas DTH is primarily chemokine driven and functions to wall off the infection and prevent further dissemination.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10379048     DOI： 10.1016/s0167-5699(98)01438-8

Source DB:  PubMed          Journal:  Immunol Today        ISSN： 0167-5699


  59 in total

1.  Effective preexposure tuberculosis vaccines fail to protect when they are given in an immunotherapeutic mode.

Authors:  J Turner; E R Rhoades; M Keen; J T Belisle; A A Frank; I M Orme
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 2.  Molecular machinations: chemokine signals in host-pathogen interactions.

Authors:  S W Chensue
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 3.  Tumour necrosis factor-alpha inhibitors and the reactivation of latent tuberculosis infection.

Authors:  Richard Long; Michael Gardam
Journal:  CMAJ       Date:  2003-04-29       Impact factor: 8.262

4.  Simultaneous measurement of antigen-stimulated interleukin-1 beta and gamma interferon production enhances test sensitivity for the detection of Mycobacterium bovis infection in cattle.

Authors:  Gareth J Jones; Chris Pirson; R Glyn Hewinson; H Martin Vordermeier
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

5.  Mycobacterial glycolipid cord factor trehalose 6,6'-dimycolate causes a decrease in serum cortisol during the granulomatous response.

Authors:  Jeffrey K Actor; Jessica Indrigo; Christopher M Beachdel; Margaret Olsen; Alice Wells; Robert L Hunter; Amitava Dasgupta
Journal:  Neuroimmunomodulation       Date:  2002 -2003       Impact factor: 2.492

6.  Circulating dendritic cells and interferon-alpha production in patients with tuberculosis: correlation with clinical outcome and treatment response.

Authors:  M Lichtner; R Rossi; F Mengoni; S Vignoli; B Colacchia; A P Massetti; I Kamga; A Hosmalin; V Vullo; C M Mastroianni
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

7.  Altered CD8(+) T cell frequency and function in tuberculous lymphadenitis.

Authors:  Nathella Pavan Kumar; Rathinam Sridhar; Luke Elizabeth Hanna; Vaithilingam V Banurekha; Mohideen S Jawahar; Thomas B Nutman; Subash Babu
Journal:  Tuberculosis (Edinb)       Date:  2014-07-01       Impact factor: 3.131

8.  Mycobacterium bovis bacillus Calmette-Guerin induces CCL5 secretion via the Toll-like receptor 2-NF-kappaB and -Jun N-terminal kinase signaling pathways.

Authors:  Patricia Méndez-Samperio; Artemisa Trejo; Aline Pérez
Journal:  Clin Vaccine Immunol       Date:  2007-11-07

9.  Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon.

Authors:  Nobuyuki Shimono; Lisa Morici; Nicola Casali; Sally Cantrell; Ben Sidders; Sabine Ehrt; Lee W Riley
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-08       Impact factor: 11.205

10.  Screening for potential adjuvants administered by the pulmonary route for tuberculosis vaccines.

Authors:  Chenchen Wang; Pavan Muttil; Dongmei Lu; Adela Ayulia Beltran-Torres; Lucila Garcia-Contreras; Anthony J Hickey
Journal:  AAPS J       Date:  2009-03-10       Impact factor: 4.009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.